[DOI] [PubMed] [Google Scholar] 29.Ahlqvist V.H., Sjqvist H., Dalman C., Karlsson H., Stephansson O., Johansson S., Magnusson C., Gardner R.M., Lee B.K
Monitoring Requirements Combining these therapies requires careful lab monitoring, including: Total and free testosterone levels Estradiol (to ensure proper aromatase balance) Complete blood count (TRT can increase hematocrit) Metabolic panel (fasting glucose, HbA1c, lipids) PSA (prostate-specific antigen) Liver and kidney function Thyroid function Labs should be checked at baseline, at 6-8 weeks after initiation, and then every 3-6 months during ongoing treatment
C., and Van der Heiden, M
Shepherd, F
In some protocols, both peptides are used strategicallyLR3 for systemic effects and DES for post-training local growthcreating a dual-phase enhancement cycle
In stage 4 , kidney damage and loss of function are severe, as reflected by a low eGFR of 1529